BUSINESS Teva Pharm directors cut their salaries in half: board member


Teva Pharm directors cut their salaries in half: board member


05:48, January 11, 2018


The logo of Teva Pharmaceutical Industries is seen on a part of their building in Jerusalem December 14, 2017. Photo: Reuters/Ammar Awad 

The board of directors at Teva Pharmaceutical Industries, which is reducing its workforce by more than a quarter as part of a global overhaul, has taken a 50 percent pay cut, a board member said on Wednesday.

The world’s biggest generic drugmaker announced its cost-cutting plan last month, setting a target to reduce costs by $3 billion by the end of 2019, from about $16.1 billion in 2017. “This pay cut that the board took upon itself was done the same day that the cuts and job reductions were discussed,” board member Dan Suesskind said at the Israel Business Conference in Jerusalem.

The Israeli company, which is laden with heavy debt, said it would reduce its workforce by 14,000 jobs.

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue